Bangkok Lab And Cosmetic Public Company (BLC) Fair Value & Analysis
Consumer Defensive · TH · Market cap 2.4B THB
Fair value as of: Jul 16, 2026
From 16 valuation models · updated 25 days ago
Share price +5.5% over the past month.
Below-average quality, screening 21% undervalued on our models.
What matters now
- Solid quality (47/100) at a price below fair value, the discount is the argument here, not the business quality.
- A fairly wide model range (3.55 THB to 6.59 THB) leaves room in how you read the outcome.
Price vs Fair Value (3 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 16, 2026.
How to read this chart
38‑month range 3.19 THB – 6.79 THB · fair‑value band 3.55 THB – 6.59 THB · the 4.20 THB price screens below the 5.07 THB fair value. Dashed = 300-day average. As of Jul 16, 2026.
Analysis
Bangkok Lab And Cosmetic Public Company (BLC) currently trades at 4.20 THB, while our model-based Fair Value estimate is 5.07 THB, implying the stock looks roughly 20.7% undervalued today. The Quality Score stands at 47/100 (below-average quality), in the Consumer Defensive sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high), always confirm before acting.
Over the trailing twelve months, Bangkok Lab And Cosmetic Public Company generated revenue of 1.7B THB at a net margin of 8.9%. Revenue declined 5.4% year over year. It earns a return on equity of 8.7%. Net debt stands at 57.5M THB. Fundamentals as of Jul 16, 2026
Our scenario range runs from 3.55 THB (bear case) to 6.59 THB (bull case); at 4.20 THB, the current price sits within that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 13% below its 52-week high and 21% above its 52-week low, currently above its 200-day average. For context, the median of 10 Consumer Defensive peers we cover trades at -26% fair-value upside, at 21%, BLC screens cheaper than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 16 models by family
Widest divergence: Growth Earnings (5.07 THB) versus Asset-Based (1.85 THB). Highest evidence: Residual Income (76).
Notify me when BLC reaches fair value
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Jul 16, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 50 · Market factors (momentum, volatility) 55
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
Bangkok Lab And Cosmetic Public Company Limited manufactures and distributes pharmaceuticals and medicinal chemical products for humans and animals in Thailand, Laos, Cambodia, Hongkong, Vietnam, and internationally.
Full company description
Bangkok Lab And Cosmetic Public Company Limited manufactures and distributes pharmaceuticals and medicinal chemical products for humans and animals in Thailand, Laos, Cambodia, Hongkong, Vietnam, and internationally. It distributes food supplements, cosmeceuticals, cosmetic, and pharmaceutical products; medicine, medical supplies, tonics, and supplements for animals; and supplementary food and herbs. The company also engages in provision of management consulting and logistic services; export and distribution of cosmeceuticals; wholesale and retail of modern medicines, dietary supplements, medical cosmetics, cosmetics, home remedies, herbal products, and medical devices; and the operation of direct marketing business. Bangkok Lab And Cosmetic Public Company Limited was founded in 1992 and is based in Ratchaburi, Thailand.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Bangkok Lab And Cosmetic Public Company reported revenue of 1.7B THB in FY2025 versus 1.1B THB in FY2021, a compound +11.3%/yr. Reported net income was 173M THB in FY2025, compounding +35.3%/yr from FY2021.
Watch BLC: get an alert when its fair value changes →
Peer Group
Household & Personal Products · 244 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Household & Personal Products median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Household & Personal Products stocks, each showing price versus our Fair Value estimate (as of Jul 16, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| The Procter & Gamble Company PG | $146.80 | $108.16 | -26% |
| Unilever PLC ULN | 1,080 MXN | 1,273 MXN | +18% |
| Hindustan Unilever Limited HINDUNILVR | ₹2,144 | ₹1,000 | -53% |
| Essity AB ESSITYA | kr 279.00 | kr 250.02 | -10% |
| Godrej Consumer Products Limited GODREJCP | ₹1,088 | ₹367.64 | -66% |
| Marico Limited MARICO | ₹846.75 | ₹233.05 | -72% |
| APR Co 278470 | 375,000 KRW | 151,222 KRW | -60% |
| Dabur India Limited DABUR | ₹429.45 | ₹181.60 | -58% |
| Kimberly-Clark de México, S. A. B. de C. V., KIMBERA | 38.07 MXN | 50.09 MXN | +32% |
| PT Unilever Indonesia Tbk UNVR | 1,730 IDR | 1,934 IDR | +12% |
Compare Bangkok Lab And Cosmetic Public Company with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Consumer Defensive stocks →
Frequently asked questions
Is Bangkok Lab And Cosmetic Public Company (BLC) overvalued or undervalued?
What is the fair value of BLC?
What is the quality score of BLC?
What is the revenue of Bangkok Lab And Cosmetic Public Company (BLC)?
What is the net profit margin of BLC?
Does Bangkok Lab And Cosmetic Public Company pay a dividend?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track Bangkok Lab And Cosmetic Public Company and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.